In the biopharmaceutical industry, cross-contamination is a significant concern, with potential impacts on product safety, efficacy, and ultimately, patient health. Cross-contamination occurs when trace amounts of one product inadvertently mix with another product, equipment, or process stream. This can lead to compromised product integrity, regulatory non-compliance, and costly recalls. From a quality assurance (QA) perspective,
The use of artificial intelligence and machine learning in the pharmaceutical industry holds immense promise for overcoming drug shortages. By leveraging predictive analytics, real-time demand forecasting, quality control, regulatory compliance, inventory management, and early warning systems, AI and ML can help ensure that patients have reliable access to the medications they need.
N-nitrosamine impurities, a class of potentially carcinogenic substances, have become a significant concern in the pharmaceutical industry. These compounds can form during the drug manufacturing process or due to degradation.
Choosing the Right Tool for the Quality Job: 6 Key Considerations for Your Quality Management System
Choosing the right QMS is an investment in your organization’s future. By carefully considering these factors, you can select a system that empowers your quality goals, streamlines operations, and sets you on the path to continuous improvement.
Validation by design thinking in the pharmaceutical industry, often referred to as “Validation 4.0”, is a shift in approach that adapts to the evolution of the industry.